Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.
Journal: Lancet (London, England)
Published: July 07, 2026
Comorbidity and comedication burden in people living with HIV in the United States: updated findings from a contemporary cohort (2020-2024).
Journal: Current medical research and opinion
Published: January 08, 2026
IL-27 effects on HIVGag-specific CD4 and CD8 T cell function.
Journal: Frontiers in virology (Lausanne, Switzerland)
Published: December 15, 2025
Angiogenic CD8 T cells from PWH induce Granzymes-dependent PAR1 activation promoting endothelial inflammation.
Journal: bioRxiv : the preprint server for biology
Published: October 01, 2025
Integration of Patient Reported Outcomes Data among People with HIV in Washington, DC: A sub-cohort of the DC Cohort Longitudinal Study.
Journal: Journal of public health (Berlin, Germany)
Published: September 08, 2025
Inflammasome Activation and Oxidative Stress in SARS-CoV-2 Infection and Symptomatic Rebound.
Journal: The Journal of infectious diseases
Published: August 19, 2025
Inflammasome activation and oxidative stress in SARS-CoV-2 infection and symptomatic rebound.
Journal: The Journal of infectious diseases
Published: August 19, 2025
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial.
Journal: Lancet (London, England)
Published: August 04, 2025
Risk of obesity, diabetes, hypertension, and major adverse cardiovascular events after a switch to an integrase inhibitor: a target trial emulation in REPRIEVE.
Journal: The lancet. HIV
Published: July 01, 2025
Biomarkers influence kidney function estimates more so than race among persons with HIV.
Journal: AIDS research and therapy
Published: June 24, 2025
Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 04, 2025
Acute Unilateral Vision Loss in a Young Woman.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 30, 2025
Last Updated: 09/26/2026